Mediport use as an acceptable standard for CAR T cell infusion

Eylon, M., Prabhu, S., John, S., King, M. J. M., Bhatt, D., Curran, K. J., Erickson, C., Karras, N. A., Phillips, C. L., Satwani, P., Hermiston, M., Southworth, E., Baumeister, S. H. C., Talano, J.-A., MacMillan, M. L., Rossoff, J., Bonifant, C. L., Myers, G. D., Rouce, R. H., … Schultz, L. M. (2023). Mediport use as an acceptable standard for CAR T cell infusion. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1239132
Authors:
Maya Eylon
Snehit Prabhu
Samuel John
Maxwell J. M. King
Dhruv Bhatt
Kevin J. Curran
Courtney Erickson
Nicole Karras
Christine L. Phillips
Prakash Satwani
Michelle L. Hermiston
Erica Southworth
Susanne H.C. Baumeister
Julie-An Talano
Margaret L. MacMillan
Jenna Rossoff
Challice L. Bonifant
Gary D. Myers
Rayne H. Rouce
Keri Toner
Timothy A. Driscoll
Emmanuel Katsanis
Dana Salzberg
Deborah Schiff
Satiro De Oliveira
Christian M. Capitini
Holly L Pacenta
Thomas Pfeiffer
Niketa C. Shah
Van Huynh
Jodi L. Skiles
Ellen Fraint
Kevin O. McNerney
Troy C. Quigg
Joerg Krueger
John A. Ligon
Vanessa A. Fabrizio
Christina Baggott
Theodore W. Laetsch
Liora M. Schultz
Affiliated Authors:
Prakash Satwani
Author Keywords:
cancer
chimeric antigen receptor t cell
immune cell engineering
immunotherapy
implanted catheter
mediport
Publication Type:
Article
Unique ID:
10.3389/fimmu.2023.1239132
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: